| Dennis G Harris, MD | |
|
420 W Morris Blvd, Ste 130, Morristown, TN 37813-2283 | |
| (423) 581-3939 | |
| (423) 318-2200 |
| Full Name | Dennis G Harris |
|---|---|
| Gender | Male |
| Speciality | Interventional Pain Management |
| Experience | 41 Years |
| Location | 420 W Morris Blvd, Morristown, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477590404 | NPI | - | NPPES |
| 3020922 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207LP2900X | Anesthesiology - Pain Medicine | MD17057 (Tennessee) | Primary |
| 208VP0000X | Pain Medicine - Pain Medicine | MD17057 (Tennessee) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Healthstar Physicians, P.c. | 5890690978 | 94 |
News Archive
Cornell researchers have found a protein that may lead to a new way to control mosquitoes that spread dengue fever, yellow fever and other diseases when they feed on humans: Prevent them from urinating as they feed on blood.
Today's anticancer drugs often work wonders against malignancies, but sometimes tumors become resistant to the effects of such drugs, and treatment fails. Medical researchers would like to find ways of counteracting such resistance, but first they must understand why and how it happens.
Celsion Corporation, a leading oncology drug development company, today announced financial results for the fourth quarter and year ended December 31, 2009. Management also highlighted the progress made in clinical trials of ThermoDox®, Celsion's heat activated liposomal encapsulation of doxorubicin, including the Company's pivotal Phase III trial for the treatment of hepatocellular carcinoma (HCC), the most common form of primary liver cancer, and recurrent chest wall breast cancer.
Scientists looking to better understand the mechanisms behind the origin and spread of melanoma tumors have uncovered a possible role for a decades-old antibacterial agent in treating these aggressive and increasingly common cancers.
› Verified 1 days ago
| Entity Name | Healthstar Physicians, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184610248 PECOS PAC ID: 5890690978 Enrollment ID: O20031203000021 |
News Archive
Cornell researchers have found a protein that may lead to a new way to control mosquitoes that spread dengue fever, yellow fever and other diseases when they feed on humans: Prevent them from urinating as they feed on blood.
Today's anticancer drugs often work wonders against malignancies, but sometimes tumors become resistant to the effects of such drugs, and treatment fails. Medical researchers would like to find ways of counteracting such resistance, but first they must understand why and how it happens.
Celsion Corporation, a leading oncology drug development company, today announced financial results for the fourth quarter and year ended December 31, 2009. Management also highlighted the progress made in clinical trials of ThermoDox®, Celsion's heat activated liposomal encapsulation of doxorubicin, including the Company's pivotal Phase III trial for the treatment of hepatocellular carcinoma (HCC), the most common form of primary liver cancer, and recurrent chest wall breast cancer.
Scientists looking to better understand the mechanisms behind the origin and spread of melanoma tumors have uncovered a possible role for a decades-old antibacterial agent in treating these aggressive and increasingly common cancers.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dennis G Harris, MD 420 W Morris Blvd, Ste 130, Morristown, TN 37813-2283 Ph: (423) 581-3939 | Dennis G Harris, MD 420 W Morris Blvd, Ste 130, Morristown, TN 37813-2283 Ph: (423) 581-3939 |
News Archive
Cornell researchers have found a protein that may lead to a new way to control mosquitoes that spread dengue fever, yellow fever and other diseases when they feed on humans: Prevent them from urinating as they feed on blood.
Today's anticancer drugs often work wonders against malignancies, but sometimes tumors become resistant to the effects of such drugs, and treatment fails. Medical researchers would like to find ways of counteracting such resistance, but first they must understand why and how it happens.
Celsion Corporation, a leading oncology drug development company, today announced financial results for the fourth quarter and year ended December 31, 2009. Management also highlighted the progress made in clinical trials of ThermoDox®, Celsion's heat activated liposomal encapsulation of doxorubicin, including the Company's pivotal Phase III trial for the treatment of hepatocellular carcinoma (HCC), the most common form of primary liver cancer, and recurrent chest wall breast cancer.
Scientists looking to better understand the mechanisms behind the origin and spread of melanoma tumors have uncovered a possible role for a decades-old antibacterial agent in treating these aggressive and increasingly common cancers.
› Verified 1 days ago
Dr. Allen Ricardo Foster, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 222 Bowman St, Suite 3, Morristown, TN 37813 Phone: 423-318-0097 Fax: 423-318-7682 | |
Jose Lopez-romero, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 230 Bowman St Ste C, Morristown, TN 37813 Phone: 423-586-3249 Fax: 423-586-3250 | |
Dr. Thomas W Lee, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1964 Jellicorse Rd, Morristown, TN 37814 Phone: 423-581-4881 Fax: 423-581-8266 | |
Mark Rogers Davenport, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1027 E Main St, Morristown, TN 37814 Phone: 423-581-5984 Fax: 423-581-0984 |